News

The study is an open label, phase I trial evaluating 1D09C3 in patients with relapsed or refractory B-cell tumors who have failed prior standard therapy, and is using

The Serono researchers assessed immune response to influenza vaccine over a four-week period in a total of 163 patients with multiple sclerosis (MS). One group of MS patients

According to an analysis of pooled data from four clinical studies, Nasonex provides effective relief of the nasal congestion often associated with seasonal allergic rhinitis. The results demonstrated

The open label safety study evaluated 397 pediatric asthma patients between the ages of six months and eight years over the course of one and a half years.

The results of a controlled driving simulator study conducted by the Washington Neuropsychological Institute show that Adderall XR, an amphetamine based product, can improve driving ability and safety

The new advances include a process to induce differentiation of functional beta cells from these stem cells that contain and release insulin in response to elevated glucose levels.

Novelos plans to submit a proposal to the Department of Health and Human Services (DHHS) in 2006 for treatment of patients with NOV-002 after acute exposure to lethal

The increase in R&D expenses for the quarter is due mainly to continued progress in Neurogen’s proprietary clinical program in insomnia and in its preclinical programs for depression

The protein identified allows the bacterial strain known as E coli 0157:H7 to obtain the iron it needs for survival in the body. Iron is a catalyst for